Skip to main content
. 2021 Aug 10;12:4840. doi: 10.1038/s41467-021-25122-4

Fig. 6. Summary of integrative characteristics associated with 5-FU-based therapy responding and non-responding tumors.

Fig. 6

a Representative pathways enriched in the R group. b Representative pathways enriched in the NR group. The figures were generated with BioRender.